Hudock Inc’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-127
Closed -$5K 769
2021
Q3
$5K Hold
127
﹤0.01% 630
2021
Q2
$5K Hold
127
﹤0.01% 611
2021
Q1
$4K Sell
127
-57
-31% -$2.16K ﹤0.01% 622
2020
Q4
$6K Buy
184
+70
+61% +$2.52K ﹤0.01% 558
2020
Q3
$4K Hold
114
﹤0.01% 557
2020
Q2
$4K Hold
114
﹤0.01% 530
2020
Q1
$3K Hold
114
﹤0.01% 515
2019
Q4
$5K Hold
114
﹤0.01% 486
2019
Q3
$4K Hold
114
﹤0.01% 516
2019
Q2
$4K Hold
114
﹤0.01% 521
2019
Q1
$4K Buy
114
+57
+100% +$2.18K ﹤0.01% 506
2018
Q4
$1K Hold
57
﹤0.01% 592
2018
Q3
$2K Buy
+57
New +$1.99K ﹤0.01% 601

Other funds holding BSX

Hudock Inc's BSX Position: Q4 2021 in Review

Hudock Inc sold out of Boston Scientific (BSX) in Q4 2021, closing a stake of 127 shares — an estimated $5K sold.

Hudock Inc first reported a position in BSX in Q3 2018 and held it in 13 quarters. The position peaked at $6K in Q4 2020. 888 funds tracked by Wall St. Rank hold BSX as of Q4 2021.

  • Hudock Inc reported no remaining Boston Scientific position as of Q4 2021 after selling out during the quarter.
  • Hudock Inc sold 127 Boston Scientific shares in Q4 2021, an estimated $5K.
  • Hudock Inc first reported a position in Boston Scientific in Q3 2018 and held it in 13 quarters.
  • Hudock Inc's Boston Scientific position peaked at $6K in Q4 2020.
  • 888 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2021.

Based on Hudock Inc's 13F filing for Q4 2021, filed 19 Jan 2022.